Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial.

Xiongcai Feng,Yansong Lin,Shuyu Zhuo,Zhi Dong,Congxiang Shao,Junzhao Ye,Bihui Zhong

The American journal of clinical nutrition（2023）

引用 1|浏览13

暂无评分

摘要

Orlistat and the experimental diet group reduced liver steatosis compared to the control group. This trial was registered at Chinese Clinical Trial Registry (ChiCTR-1900027172). http://www.chictr.org.cn.

查看译文

关键词

Asian population,experimental diet,metabolic-associated fatty liver disease,obesity,orlistat

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要